Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
33%
Ph phase_4
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (33.3%)
Phase 42 (66.7%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

NCT01256151
completedphase_4

A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets

NCT01322867
unknownphase_4

Preoperative Use of Alprazolam and Hydroxyzine in Anxiety

NCT04184141

Clinical Trials (3)

Showing 3 of 3 trials
NCT01256151Phase 1

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

Completed
NCT01322867Phase 4

A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets

Completed
NCT04184141Phase 4

Preoperative Use of Alprazolam and Hydroxyzine in Anxiety

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3